Crossmark

Quantifying antiviral activity optimizes drug combinations against hepatitis C virus infection

Crossref DOI link: https://doi.org/10.1073/pnas.1610197114

Published Online: 2017-02-07

Published Print: 2017-02-21

Update policy: https://doi.org/10.1073/pnas.cm10313

Authors

Koizumi, Yoshiki

Ohashi, Hirofumi

Nakajima, Syo

Tanaka, Yasuhito

Wakita, Takaji

Perelson, Alan S.

Iwami, Shingo

Watashi, Koichi
Funding

Funding for this research was provided by:

Japan Science and Technology Agency (PRESTO)

Japan Science and Technology Agency (CREST)

Japan Science and Technology Agency (RISTEX)
License Information

Version of Record valid from 2017-08-07
More Information

Publication History

Published: 2017-02-07